Early Multimodal Neuromonitoring For Spontaneous Intracerebral Hemorrhage (ICH)

The investigators intend to assess the predictive value of early (first 48 hours) multimodal neuromonitoring parameters concerning late survival in critically ill intracerebral hemorrhage (ICH) patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Intracerebral Hemorrhage Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebral Hemorrhage Cerebral Perfusion Pressure Cerebrovascular Disorders Critical Illness Critically Ill Disease Attributes Hemorrhage Intracranial Hemorrhages Intracranial Pressure Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Prognostic Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centro Hospitalar Universitário de São João

Porto, Portugal

About this study

Retrospective observational study based on analyzing the first 48 hours of the multimodal neuromonitoring signal, from spontaneous ICH patients, whose treatment includes invasive intraparenchymal neuromonitoring, treated from January 2015 to September 2021 in a tertiary hospital.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Spontaneous Intracerebral Hemorrhage
ICU admission
Need of Sedation and Ventilatory Support
Need of Intracerebral Neuromonitoring

Exclusion criteria

Etiology for Intracerebral hemorrhage such as tumor, vascular malformation, ischemic transformation.

Treatment and study plan

Multimodal Neuromonitoring

Diagnostic Test

Invasive Multimodal Neuromonitoring

Primary outcomes

Survival

Time frame: 1 and 6 months

1 and 6 months survival
Functional Outcome

Time frame: 6 month

6 month functional outcome with Modified Rankin Scale - 0 (No symptoms); 1 (No significant disability); 2 (Slight disability); 3 (Moderate disability); 4 (Moderately Severe Disability); 5 (Severe Disability); 6 (Dead).

Sponsors and collaborators

Lead sponsor

Universidade do Porto

Other

Registry information

Official study title

Early Multimodal Neuromonitoring Parameters as Prognostic Factors For Critically Ill Spontaneous ICH Patients

Important dates

Study start: 2015
Primary completion: 2022
Study completion: 2023
First posted: Aug 15, 2022
Registry last updated: Feb 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting